Renowned Purdue Researcher Earns Another FDA Approval 

What is expected to be a blockbuster drug for prostate cancer is now on the market. And it was discovered by the legendary Dr. Philip Low at Purdue University. In the Business of Health, we look at his latest FDA approval and rich legacy.